m3.com: Japan's Physician Network, CRM & WebMD Explained
Learn about m3.com, Japan's dominant physician network with 90% market share. This analysis compares its CRM and content model to LinkedIn and WebMD.
Back to Articles
Articles tagged with “pharmaceutical-marketing”
The SCDC Framework for AI Messaging in Life Sciences
Learn the SCDC framework for differentiated messaging of high-value AI solutions in life sciences. This guide explains how to tailor content for diverse stakeho
Top 10 MLR Review Software: A Guide for Life Sciences
A comprehensive guide to MLR review software for pharma and life sciences. Compare the top 10 platforms and learn how to ensure marketing content compliance.
What is HCP Marketing? A Guide for the Pharma Industry
Updated 2026 guide to HCP marketing in the pharmaceutical industry. Covers AI-driven personalization, omnichannel engagement, digital strategies, mobile-first content, and the latest FDA and IFPMA regulatory developments.
A Guide to Next Best Action (NBA) in Pharma Marketing
An overview of Next Best Action (NBA) in pharma marketing. Learn how AI-driven NBA strategies optimize HCP engagement, with 2026 updates on agentic AI, Salesforce Agentforce, and the PharmaForceIQ-Aktana acquisition.
Pharmaceutical Remarketing: A Guide to Platform Compliance
An educational guide to executing compliant pharmaceutical remarketing. Explores platform policies on Google, Meta, LinkedIn, and Reddit, plus data privacy. Updated for 2025-2026 with Meta's health-data restrictions, FDA enforcement escalation, Google policy changes, and HIPAA tracking updates.
Pharmaceutical Mobile App Usage and Engagement Strategies
This report details how pharmaceutical companies use mobile apps for patient support, medication adherence, and data collection, including the 2023-2024 digital therapeutics shakeout, FDA regulatory updates through 2026, and emerging AI-powered engagement strategies.